Tag Archives: EFPIA

Online Patient Library Set for European Launch

By Philip Ward. The new Internet Library from the European Patients’ Academy (EUPATI) will come online towards the end of 2015, and will be available in seven European languages (English, French, Spanish, Italian, German, Polish and Russian), project director Jan Geissler revealed at last week’s workshop held in Warsaw, Poland, and organized by EUPATI.
Posted in Europe, healthcare, Patient Communication, patient education | Also tagged , , , , | Leave a comment

Industry Takes EU to Task Over Pharmacovigilance Fees

Europe’s leading pharma industry bodies — EFPIA, EGA, EuropaBio, AESGP and EUCOPE — have issued a joint statement to express concern about “the increasing financial burden of regulatory costs incurred since the adoption of the pharmacovigilance package in 2010″.  Procedural fees such as for pharmacovigilance referrals, they argue, have been significantly increased in the last […]
Posted in Europe, Global, Regulatory | Also tagged , , , , , , | Leave a comment

EU Clinical Trials Agreement 'Compromised', Says Industry

European Union (EU) regulators reached agreement today on the much-vaunted Clinical Trials Regulation. The regulation harmonizes the rules for the conduct of clinical trials in the EU and the ‘acceptability’ of the resulting data, and palces further safeguards on the safety of trial subjects. The legislation’s aim is to facilitate and expedite the authorization procedure […]
Posted in Europe, Global, R&D, Regulatory | Also tagged , , , | Leave a comment

Pharma's Transparency Troubles

Transparency Troubles for Pharma High prices, murky financial relations, and a reluctance to disclose clinical data are undermining public trust in industry and the research enterprise, writes Jill Wechsler It seems like open season on the pharmaceutical industry. Academics and consumer activists charge pharma companies with hiding clinical trial information on medical product safety, fueling […]
Posted in Europe, FDA, Guest Blog, Op-Ed, Regulatory | Also tagged , , , , | Leave a comment

European Pharma Gears Up for Horizon 2020

European Pharma Gears Up for Horizon 2020 The ink is not yet dry on the European Union’s Horizon 2020 agreement to invest some €70 billion ($92 bn) in research over the next seven years, and already contenders for funding are jostling for attention. Europe’s biggest drug industry association EFPIA scored something of a coup by […]
Posted in Europe, Global, Guest Blog, Op-Ed | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta